How do short‐term practice effects compare to biomarkers of Alzheimer’s disease?
Short-term practice effects on cognitive tests appear to be a sensitive marker in late life cognitive disorders, as they separated groups better than commonly-used biomarkers in AD. Further refinement of short-term practice effects as a tool for clinical diagnosis, prognostic indication, and enrichment of clinical trials seems warranted.
Authors
- Vincent Koppelmans (ORCID: https://orcid.org/0000-0003-2036-7603)
- John M. Hoffman (ORCID: https://orcid.org/0000-0001-9492-2206)
- Kevin M. Duff (ORCID: https://orcid.org/0000-0002-9336-2400)
- Dustin B. Hammers (ORCID: https://orcid.org/0000-0002-1644-2618)
- Jace B. King (ORCID: https://orcid.org/0000-0002-0206-0475)
Institutions
- Oregon Health & Science University (US)
- University of Utah (US)
- Huntsman Cancer Institute (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.086315
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00